Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2013, Article ID 367325, 10 pages
http://dx.doi.org/10.1155/2013/367325
Research Article

Possible Involvement of Foxp3+ Regulatory T Cells in the Development of Immune-Mediated Pancreatitis in MRL/Mp Mice Treated with Polyinosinic:Polycytidylic Acid

The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Fumizono, Moriguchi, Osaka 570-8507, Japan

Received 23 February 2013; Accepted 29 April 2013

Academic Editor: Arezou Khosroshahi

Copyright © 2013 Masanori Koyabu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Uchida, K. Okazaki, Y. Konishi et al., “Clinical analysis of autoimmune-related pancreatitis,” The American Journal of Gastroenterology, vol. 95, pp. 2788–2794, 2000. View at Google Scholar
  2. J. Kino-Ohsaki, I. Nishimori, M. Morita et al., “Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome,” Gastroenterology, vol. 110, no. 5, pp. 1579–1586, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Okazaki, K. Uchida, and T. Fukui, “Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis,” Journal of Gastroenterology, vol. 43, no. 6, pp. 409–418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Uchida, T. Kusuda, M. Koyabu et al., “Regulatory T cells in type 1 autoimmune pancreatitis,” International Journal of Rheumatology, vol. 2012, Article ID 795026, 6 pages, 2012. View at Publisher · View at Google Scholar
  5. D. L. Finkelberg, D. Sahani, V. Deshpande et al., “Autoimmune pancreatitis,” The New England Journal of Medicine, vol. 355, pp. 2670–2676, 2006. View at Google Scholar
  6. K. Okazaki and T. Chiba, “Autoimmune related pancreatitis,” Gut, vol. 51, no. 1, pp. 1–4, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Tsubata, T. Tsubata, H. Hiai et al., “Autoimmune disease of exocrine organ immunodeficient model for Sjögren’s syndrome,” European Journal of Immunology, vol. 26, pp. 2742–2748, 1996. View at Google Scholar
  8. H. Kanno, M. Nose, J. Itoh, Y. Taniguchi, and M. Kyogoku, “Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism,” Clinical and Experimental Immunology, vol. 89, no. 1, pp. 68–73, 1992. View at Google Scholar · View at Scopus
  9. W. Mustafa, J. Zhu, G. Deng et al., “Augmented levels of macrophage and TH1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis,” Clinical and Experimental Immunology, vol. 112, no. 3, pp. 389–396, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Haneji, H. Hamano, K. Yanagi et al., “Identification of a-fodrin as a candidate autoantigen in primary Sjögren’s syndrome,” Science, vol. 276, pp. 604–607, 1998. View at Google Scholar
  11. Y. Sakaguchi, M. Inaba, M. Tsuda et al., “The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy,” Clinical and Experimental Immunology, vol. 152, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. M. Qu, T. Miyazaki, M. Terada et al., “A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid,” Clinical and Experimental Immunology, vol. 129, no. 1, pp. 27–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Uchida, K. Okazaki, T. Nishi et al., “Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin,” Laboratory Investigation, vol. 82, no. 4, pp. 411–424, 2002. View at Google Scholar · View at Scopus
  14. M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi, “Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation,” Journal of Experimental Medicine, vol. 184, no. 2, pp. 387–396, 1996. View at Google Scholar · View at Scopus
  15. H. Miyoshi, K. Uchida, T. Taniguchi et al., “Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis,” Pancreas, vol. 36, no. 2, pp. 133–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Sakaguchi, M. Inaba, K. Kusafuka, K. Okazaki, and S. Ikehara, “Establishment of animal models for three types of pancreatitis and analyses of regeneration mechanisms,” Pancreas, vol. 33, no. 4, pp. 371–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Sarles, J. C. Sarles, R. Muratore, and C. Guien, “Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease?” The American Journal of Digestive Diseases, vol. 6, no. 7, pp. 688–698, 1961. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Yoshida, F. Toki, T. Takeuchi, S. I. Watanabe, K. Shiratori, and N. Hayashi, “Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis,” Digestive Diseases and Sciences, vol. 40, no. 7, pp. 1561–1568, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Ito, I. Nakano, S. Koyanagi et al., “Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy,” Digestive Diseases and Sciences, vol. 42, pp. 1458–1468, 1997. View at Google Scholar
  20. A. Horiuchi, S. Kawa, T. Akamatsu et al., “Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: a case report and review of the Japanese literature,” American Journal of Gastroenterology, vol. 93, no. 2, pp. 260–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. E. D. Murphy and J. B. Roths, “Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice,” in Genetic Control of Autoimmune Disease, N. R. Rose, P. E. Bigazzi, and N. L. Warner, Eds., pp. 207–220, Elsevier, New York, NY, USA, 1978. View at Google Scholar
  22. B. Andrews, R. A. Eisenberg, A. N. Theofilopoulos et al., “Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains,” Journal of Experimental Medicine, vol. 148, no. 5, pp. 1198–1215, 1978. View at Google Scholar · View at Scopus
  23. E. D. Murphy, “Lymphoproliferation, (lpr) and other single locus models for murine lupus,” in Immunological Defects in Laboratory Animals, M. E. Gershwin and B. Merchant, Eds., pp. 143–173, Plenum Press, New York, NY, USA, 1981. View at Google Scholar
  24. M. Asada, A. Nishio, T. Akamatsu et al., “Analysis of humoral immune response in experimental autoimmune pancreatitis in mice,” Pancreas, vol. 39, no. 2, pp. 224–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. N. Theofilopoulos and F. J. Dixon, “Murine models of systemic lupus erythematosus,” Advances in Immunology, vol. 37, pp. 269–390, 1985. View at Google Scholar · View at Scopus
  26. S. Suvas, A. K. Azkur, B. S. Kim et al., “CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions,” The Journal of Immunology, vol. 172, pp. 4123–4132, 2004. View at Google Scholar
  27. M. Hesse, C. A. Piccirillo, Y. Belkaid et al., “The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells,” Journal of Immunology, vol. 172, no. 5, pp. 3157–3166, 2004. View at Google Scholar · View at Scopus
  28. S. Hori, T. L. Carvalho, and J. Demengeot, “CD25+CD4+ regulatory T cells suppress CD4+T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice,” European Journal of Immunology, vol. 32, pp. 1282–1291, 2002. View at Google Scholar
  29. Y. Belkaid, C. A. Piccirillo, S. Mendez et al., “CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity,” Nature, vol. 420, pp. 502–507, 2002. View at Google Scholar
  30. M. D. Taylor, L. LeGoff, A. Harris, E. Malone, J. E. Allen, and R. M. Maizels, “Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo,” Journal of Immunology, vol. 174, no. 8, pp. 4924–4933, 2005. View at Google Scholar · View at Scopus
  31. S. Wei, I. Kryczek, and W. Zou, “Regulatory T-cell compartmentalization and trafficking,” Blood, vol. 108, no. 2, pp. 426–431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Belkaid and B. T. Rouse, “Natural regulatory T cells in infectious disease,” Nature Immunology, vol. 6, pp. 353–360, 2005. View at Google Scholar
  33. T. Nakajima, K. Ueki-Maruyama, T. Oda et al., “Regulatory T-cells infiltrate periodontal disease tissues,” Journal of Dental Research, vol. 84, pp. 639–643, 2005. View at Google Scholar
  34. T. Okui, H. Ito, T. Honda, R. Amanuma, H. Yoshie, and K. Yamazaki, “Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions,” Oral Microbiology and Immunology, vol. 23, no. 1, pp. 49–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Makita, T. Kanai, S. Oshima et al., “CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells,” Journal of Immunology, vol. 173, no. 5, pp. 3119–3130, 2004. View at Google Scholar · View at Scopus
  36. I. M. de Kleer, L. R. Wedderburn, L. S. Taams et al., “CD4CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting from of juvenile idiopathic arthritis,” Journal of Immunology, vol. 172, no. 10, pp. 6435–6443, 2004. View at Google Scholar · View at Scopus
  37. D. Cao, R. van Vollenhoven, L. Klareskog, C. Trollmo, and V. Malmström, “CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease,” Arthritis Research & Therapy, vol. 6, no. 4, pp. R335–R346, 2004. View at Google Scholar · View at Scopus
  38. S. Beissert, A. Schwarz, and T. Schwarz, “Regulatory T cells,” Journal of Investigative Dermatology, vol. 126, no. 1, pp. 15–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. A. Peterson, “Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression,” Toxicologic Pathology, vol. 40, pp. 186–204, 2012. View at Google Scholar
  40. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Koyabu, K. Uchida, H. Miyoshi et al., “Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases,” Journal of Gastroenterology, vol. 45, no. 7, pp. 732–741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. C. R. Monk, M. Spachidou, F. Rovis et al., “MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1180–1184, 2005. View at Publisher · View at Google Scholar · View at Scopus